{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Bauer I"],"funding":["Austrian Science Fund FWF","Ministry of Health, State of Israel","Medizinische Universität Innsbruck"],"pagination":["2773"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6905131"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["10"],"pubmed_abstract":["Current suboptimal treatment options of invasive fungal infections and emerging resistance of the corresponding pathogens urge the need for alternative therapy strategies and require the identification of novel antifungal targets. Aspergillus fumigatus is the most common airborne opportunistic mold pathogen causing invasive and often fatal disease. Establishing a novel in vivo conditional gene expression system, we demonstrate that downregulation of the class 1 lysine deacetylase (KDAC) RpdA leads to avirulence of A. fumigatus in a murine model for pulmonary aspergillosis. The xylP promoter used has previously been shown to allow xylose-induced gene expression in different molds. Here, we demonstrate for the first time that this promoter also allows in vivo tuning of A. fumigatus gene activity by supplying xylose in the drinking water of mice. In the absence of xylose, an A. fumigatus strain expressing rpdA under control of the xylP promoter, rpdA xylP , was avirulent and lung histology showed significantly less fungal growth. With xylose, however, rpdA xylP displayed full virulence demonstrating that xylose was taken up by the mouse, transported to the site of fungal infection and caused rpdA induction in vivo. These results demonstrate that (i) RpdA is a promising target for novel antifungal therapies and (ii) the xylP expression system is a powerful new tool for in vivo gene silencing in A. fumigatus."],"journal":["Frontiers in microbiology"],"pubmed_title":["The Lysine Deacetylase RpdA Is Essential for Virulence in Aspergillus fumigatus."],"pmcid":["PMC6905131"],"funding_grant_id":["Infect-ERA I1616","W 1253"],"pubmed_authors":["Petzer V","Orasch T","Haas H","Abt B","Osherov N","Graessle S","Misslinger M","Bauer I","Shadkchan Y","Dietl AM"],"additional_accession":[]},"is_claimable":false,"name":"The Lysine Deacetylase RpdA Is Essential for Virulence in Aspergillus fumigatus.","description":"Current suboptimal treatment options of invasive fungal infections and emerging resistance of the corresponding pathogens urge the need for alternative therapy strategies and require the identification of novel antifungal targets. Aspergillus fumigatus is the most common airborne opportunistic mold pathogen causing invasive and often fatal disease. Establishing a novel in vivo conditional gene expression system, we demonstrate that downregulation of the class 1 lysine deacetylase (KDAC) RpdA leads to avirulence of A. fumigatus in a murine model for pulmonary aspergillosis. The xylP promoter used has previously been shown to allow xylose-induced gene expression in different molds. Here, we demonstrate for the first time that this promoter also allows in vivo tuning of A. fumigatus gene activity by supplying xylose in the drinking water of mice. In the absence of xylose, an A. fumigatus strain expressing rpdA under control of the xylP promoter, rpdA xylP , was avirulent and lung histology showed significantly less fungal growth. With xylose, however, rpdA xylP displayed full virulence demonstrating that xylose was taken up by the mouse, transported to the site of fungal infection and caused rpdA induction in vivo. These results demonstrate that (i) RpdA is a promising target for novel antifungal therapies and (ii) the xylP expression system is a powerful new tool for in vivo gene silencing in A. fumigatus.","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019","modification":"2024-11-20T00:36:52.497Z","creation":"2020-05-21T23:51:26Z"},"accession":"S-EPMC6905131","cross_references":{"pubmed":["31866965"],"doi":["10.3389/fmicb.2019.02773"]}}